References
- Kane S, Admani S. COVID-19 pandemic leading to the accelerated development of a virtual health model for isotretinoin. J Dermatol Nurses Assoc. 2021;13(1):1–2. doi: 10.1097/JDN.0000000000000595.
- Falotico JM, Gu L, Lipner SR. Not just pimple popping: the utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;21(10):4105–4106. doi: 10.1111/jocd.15256.
- Onyekweli T, Agarwal A, Jaklitsch E, et al. Teledermatology isotretinoin management for moderate-to-severe acne reveals similar outcomes to in-person management: a retrospective study. JAAD Int. 2023;11:126–128. doi: 10.1016/j.jdin.2023.02.009.
- Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36–38. doi: 10.1111/jocd.14606.
- Das S, Su MY, Kvedar JC, et al. Asynchronous telemedicine for isotretinoin management: a direct care pilot. J Am Acad Dermatol. 2022;86(1):184–186. doi: 10.1016/j.jaad.2021.01.039.